Showing results (231-240 of 258) with videos related to

Sort By:
Pageof 26
Therapeutic Advances in Musculoskeletal Disease|March 30, 2026
The protocol for a patient-driven online prospective European observational cohort aiming to determine risk factors for the development of psoriatic arthritis among people living with psoriasis: the HIPPOCRATES Prospective Observational StudyTeresa Grohmann, Timeo Mtenga, David Kerr, et al.
Gut|November 1, 2024
Pharmacological activation of STAT1-GSDME pyroptotic circuitry reinforces epigenetic immunotherapy for hepatocellular carcinomaYalin Tu, Haoran Wu, Chengpeng Zhong, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker studyEnric Domingo, Luke Freeman-Mills, Emily Rayner, et al.
The Lancet. Oncology|October 1, 2011
Delivering affordable cancer care in high-income countriesRichard Sullivan, Jeffrey Peppercorn, Karol Sikora, et al.
Scientific Reports|May 21, 2015
A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancerNada A Al-Tassan, Nicola Whiffin, Fay J Hosking, et al.
Progress in Cardiovascular Diseases|May 13, 2023
Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology SocietyAndrea M Yeung, Jingtong Huang, Ambarish Pandey, et al.
Lancet (London, England)|June 1, 2020
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort studyLennard Yw Lee, Jean-Baptiste Cazier, Vasileios Angelis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2014
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysisDan Rosmarin, Claire Palles, David Church, et al.
The Lancet. Oncology|August 28, 2020
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort studyLennard Y W Lee, Jean-Baptiste Cazier, Thomas Starkey, et al.
Gut|April 12, 2012
Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individualsMalcolm G Dunlop, Albert Tenesa, Susan M Farrington, et al.
Pageof 26